Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation

被引：0
|
作者：
Tadashi Hanafusa
Toshiyuki Shinji
Hidenori Shiraha
Kazuhiro Nouso
Yoshiaki Iwasaki
Eichiro Yumoto
Toshiro Ono
Norio Koide
机构：
[1] Okayama University Advanced Science Research Center,Department of Radiation Research, Shikata Laboratory
[2] Okayama University Graduate School of Medicine and Dentistry,Department of Laboratory Medicine
[3] Okayama University Graduate School of Medicine and Dentistry,First Department of Internal Medicine
[4] Albert Einstein College of Medicine,Department of Microbiology and Immunology
来源：
BMC Cancer | / 5卷
关键词：
HepG2 Cell; Promoter Hypermethylation; Electrophoresis Mobility Shift Assay; Cancer Profile Array; Human Hepatoblastoma Cell Line HepG2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Regulatory role of rpL3 in cell response to nucleolar stress induced by Act D in tumor cells lacking functional p53
    Russo, Annapina
    Pagliara, Valentina
    Albano, Francesco
    Esposito, Davide
    Sagar, Vinay
    Loreni, Fabrizio
    Irace, Carlo
    Santamaria, Rita
    Russo, Giulia
    CELL CYCLE, 2016, 15 (01) : 41 - 51
  • [32] Tumor-specific mutation spectra in the human p53 gene: From carcinogen "fingerprints" to functional consequences
    Hernandez, T
    Hainaut, P
    JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS, 1998, 16 (01): : 31 - 45
  • [33] Erratum: DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53
    Ella Kim
    Nils Albrechtsen
    Wolfgang Deppert
    Oncogene, 1997, 15 : 2385 - 2385
  • [34] Immune responses to p53 in patients with cancer:enrichment in tetramer+p53 peptide-specific T cells and regulatory T cells at tumor sites
    Albers, AE
    Ferris, RL
    Kim, GG
    Chikamatsu, K
    DeLeo, AB
    Whiteside, TL
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (11) : 1072 - 1081
  • [35] A novel p53 binding sequence in intron 3 of the human MDM2 proto-oncogene:: A putative additional p53-dependent promoter
    Liang, H
    Lunec, J
    BRITISH JOURNAL OF CANCER, 1998, 78 : 18 - 18
  • [36] Docetaxel and 5-fluorouracil induce human p53 tumor suppressor gene transcription via a short sequence at core promoter element
    Chuang, Jui-Chuan
    Sheu, Gwo-Tarng
    Wang, Pi-Chieh
    Liao, Fu-Tien
    Liu, Wen-Shan
    Huang, Chuan-Fu
    Tseng, Mei-Hui
    Wu, Ming-Fang
    TOXICOLOGY IN VITRO, 2012, 26 (05) : 678 - 685
  • [37] A promoter function of the CCCGGG Sma I recognition sequence and its specific role in determining p53 status and identifying DNA damaging agents
    Yang, AL
    Festing, MFW
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (02) : 506 - 510
  • [38] WILD-TYPE P53 CAN MEDIATE SEQUENCE-SPECIFIC TRANSACTIVATION OF AN INTERNAL PROMOTER WITHIN THE MDM2 GENE
    JUVEN, T
    BARAK, Y
    ZAUBERMAN, A
    GEORGE, DL
    OREN, M
    ONCOGENE, 1993, 8 (12) : 3411 - 3416
  • [39] Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC
    Yang, Qin
    Zhu, Lin
    Ye, Mao
    Zhang, Bin
    Zhan, Peihe
    Li, Hui
    Zou, Wen
    Liu, Jing
    FRONTIERS IN GENETICS, 2022, 13
  • [40] EXPRESSION OF A MUTANT P53 EPITOPE FUSED WITH THE ADENOVIRUS E3 LEADER SEQUENCE IN TUMOR-CELLS OVERCOMES GAMMA-IFN DEPENDENCE OF LYSIS BY P53-SPECIFIC CTL
    CIERNIK, IF
    YANUCK, M
    BERZOFSKY, JA
    CARBONE, DP
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 163 - 163
12345